XBI vs. SPY
XBI (SPDR S&P Biotech ETF) and SPY (State Street SPDR S&P 500 ETF) are both exchange-traded funds - XBI is a Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index, while SPY is a S&P 500 fund tracking the S&P 500 Index. Both are passively managed. Over the past 10 years, XBI returned 8.53%/yr vs 15.48%/yr for SPY. A 0.61 correlation means they provide meaningful diversification when combined. XBI charges 0.35%/yr vs 0.09%/yr for SPY.
Performance
XBI vs. SPY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XBI achieves a 9.42% return, which is significantly lower than SPY's 11.33% return. Over the past 10 years, XBI has underperformed SPY with an annualized return of 8.53%, while SPY has yielded a comparatively higher 15.48% annualized return.
XBI
- 1D
- 2.77%
- 1M
- -0.28%
- YTD
- 9.42%
- 6M
- 8.61%
- 1Y
- 62.35%
- 3Y*
- 15.65%
- 5Y*
- 1.14%
- 10Y*
- 8.53%
SPY
- 1D
- 0.38%
- 1M
- 4.60%
- YTD
- 11.33%
- 6M
- 11.25%
- 1Y
- 28.50%
- 3Y*
- 22.58%
- 5Y*
- 13.91%
- 10Y*
- 15.48%
XBI vs. SPY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XBI SPDR S&P Biotech ETF | 9.42% | 35.89% | 1.01% | 7.60% | -25.87% | -20.45% | 48.33% | 32.56% | -15.28% | 43.77% |
SPY State Street SPDR S&P 500 ETF | 11.33% | 17.72% | 24.89% | 26.18% | -18.18% | 28.73% | 18.33% | 31.22% | -4.57% | 21.71% |
Correlation
The correlation between XBI and SPY is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.51 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.54 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.57 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.57 |
Correlation (All Time) Calculated using the full available price history since Feb 7, 2006 | 0.61 |
The correlation between XBI and SPY has been stable across timeframes, ranging from 0.51 to 0.61 - a consistent structural relationship.
XBI vs. SPY - Sectors Allocation Comparison
Sectors
XBI
SPY
Healthcare
Financial Services
Basic Materials
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
XBI
SPY
Financial Services
XBI
SPY
Basic Materials
XBI
SPY
Communication Services
XBI
-
SPY
Consumer Cyclical
XBI
-
SPY
Consumer Defensive
XBI
-
SPY
Energy
XBI
-
SPY
Industrials
XBI
-
SPY
Real Estate
XBI
-
SPY
Technology
XBI
-
SPY
Utilities
XBI
-
SPY
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XBI vs. SPY — Risk / Return Rank
XBI
SPY
XBI vs. SPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Biotech ETF (XBI) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XBI | SPY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.03 | ||
| Sortino ratioReturn per unit of downside risk | +0.03 | ||
| Omega ratioGain probability vs. loss probability | 1.40 | 1.44 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | 6.45 | 3.22 | +3.22 |
| Martin ratioReturn relative to average drawdown | 19.53 | 14.99 | +4.54 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XBI | SPY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.45 | 2.42 | +0.03 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.04 | 0.82 | -0.78 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.27 | 0.87 | -0.60 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.36 | 0.59 | -0.22 |
Drawdowns
XBI vs. SPY - Drawdown Comparison
The maximum XBI drawdown since its inception was -63.89%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for XBI and SPY.
Loading charts...
Drawdown Indicators
| XBI | SPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.89% | -55.19% | -8.70% |
Max Drawdown (1Y)Largest decline over 1 year | -9.72% | -8.88% | -0.84% |
Max Drawdown (3Y)Largest decline over 3 years | -32.99% | -18.76% | -14.23% |
Max Drawdown (5Y)Largest decline over 5 years | -54.71% | -24.50% | -30.21% |
Max Drawdown (10Y)Largest decline over 10 years | -63.89% | -33.72% | -30.17% |
Current DrawdownCurrent decline from peak | -22.89% | -0.33% | -22.56% |
Average DrawdownAverage peak-to-trough decline | -20.93% | -9.05% | -11.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.20% | 1.91% | +1.29% |
Volatility
XBI vs. SPY - Volatility Comparison
SPDR S&P Biotech ETF (XBI) has a higher volatility of 9.69% compared to State Street SPDR S&P 500 ETF (SPY) at 2.79%. This indicates that XBI's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XBI | SPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.69% | 2.79% | +6.90% |
Volatility (6M)Calculated over the trailing 6-month period | 20.31% | 8.91% | +11.40% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.60% | 11.82% | +13.78% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.20% | 17.05% | +15.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.00% | 17.93% | +14.07% |
XBI vs. SPY - Expense Ratio Comparison
XBI has a 0.35% expense ratio, which is higher than SPY's 0.09% expense ratio.
Dividends
XBI vs. SPY - Dividend Comparison
XBI's dividend yield for the trailing twelve months is around 0.33%, less than SPY's 0.98% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SPY State Street SPDR S&P 500 ETF | 0.98% | 1.07% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% |
XBI SPDR S&P Biotech ETF | 0.33% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Frequently Asked Questions
XBI and SPY have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XBI has higher volatility (9.69%) compared to SPY (2.79%). In terms of maximum drawdown, XBI dropped -63.89% vs SPY's -55.19%.
On 10-year performance, SPY leads with 15.48% vs 8.53% for XBI. On fees, SPY is cheaper at 0.09% per year. On volatility, SPY has been the lower-risk option at 2.79%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, SPY has performed better with a 15.48% return vs 8.53%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SPY is cheaper with a 0.09% expense ratio, compared with 0.35% for XBI.
SPY has the higher dividend yield at 0.98%, compared with 0.33% for XBI.
XBI is categorized as Health & Biotech Equities, while SPY is S&P 500. XBI tracks S&P Biotechnology Select Industry Index, while SPY tracks S&P 500 Index. Their fees differ too: 0.35% for XBI and 0.09% for SPY.
XBI currently has the higher Sharpe Ratio (2.45 vs 2.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XBI and SPY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer